Flupentixol use and adverse reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study
- 9 July 2013
- journal article
- research article
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 264 (2) , 131-141
Abstract
This study compares the first-generation antipsychotic (FGA) flupentixol to haloperidol and common second-generation antipsychotics (SGAs) as to drug utilization and severe adverse drug reactions (ADRs) in clinical treatment of schizophrenia inpatients using data from the drug safety program Arzneimittelsicherheit in der Psychiatrie (AMSP). AMSP drug utilization and reported ADR data were analyzed. Type and frequency of severe ADRs attributed to flupentixol were compared with haloperidol, clozapine, olanzapine, quetiapine, risperidone and amisulpride in a total of 56,861 schizophrenia inpatients exposed to these drugs. In spite of increasing prescription of SGAs, flupentixol was consistently used in schizophrenic inpatients (about 5 %) over time. Reporting rates of severe ADR ranged from 0.38 to 1.20 % for the individual antipsychotics (drugs imputed alone); flupentixol ranked lowest. The type of ADR differed considerably; as to severe EPMS, flupentixol (0.27 %), such as risperidone (0.28 %), held an intermediate position between haloperidol/amisulpride (0.55/0.52 %) and olanzapine/quetiapine (<0.1 %). The study is a heuristic approach, not a confirmatory test. Flupentixol has a stable place in the treatment of schizophrenia in spite of the introduction of different SGAs. Comparative ADR profiles suggest an intermediate position between FGAs and SGAs for flupentixol in clinical practice.Keywords
This publication has 36 references indexed in Scilit:
- International Consensus Study of Antipsychotic DosingAmerican Journal of Psychiatry, 2010
- Striatal D2/D3 Receptor Occupancy, Clinical Response and Side Effects with Amisulpride: An Iodine-123-Iodobenzamide SPET StudyPharmacopsychiatry, 2008
- Severe and Uncommon Involuntary Movement Disorders due to Psychotropic DrugsPharmacopsychiatry, 2004
- The AMÜP Study for Drug Surveillance in Psychiatry - a Summary of Inpatient DataPharmacopsychiatry, 2004
- In Search of Madness: Schizophrenia and NeuroscienceThe Journal of Clinical Psychiatry, 2002
- Antipsychotic Medication Adherence: Is There a Difference Between Typical and Atypical Agents?American Journal of Psychiatry, 2002
- Bodyweight Gain with Atypical AntipsychoticsDrug Safety, 2001
- Role of Antipsychotic Polypharmacotherapy in the Treatment of SchizophreniaCNS Drugs, 1999
- Confidence intervals for a binomial proportionStatistics in Medicine, 1993
- The Effects of Phenothiazines on Endocrine Function: IThe British Journal of Psychiatry, 1974